Concepedia

Zenjiro Sampei

ZS

Statistics

Publications

10

Citations

1.2K

H-Index

10

Active since

2012

Affiliations

Chugai Pharma (United States)(Current)

Nara Medical University

Zenjiro Sampei is an author at Chugai Pharma (United States) specializing in monoclonal antibodies, antibody characterization, and immunology.

Publications per year

2012–2023

10

Publications

10

A bispecific antibody to factors IXa and X restores factor VIII hemostatic activity in a hemophilia A model

Takehisa Kitazawa, Tomoyuki Igawa, Zenjiro Sampei et al. · Nature Medicine · 2012 · 496 citations

Medicine, Hematology, Immunology +17

Identification and Multidimensional Optimization of an Asymmetric Bispecific IgG Antibody Mimicking the Function of Factor VIII Cofactor Activity

Zenjiro Sampei, Tomoyuki Igawa, Tetsuhiro Soeda et al. · PLoS ONE · 2013 · 325 citations · Full text

Pharmacy, Biotechnology, Medicinal Chemistry +17

Long lasting neutralization of C5 by SKY59, a novel recycling antibody, is a potential therapy for complement-mediated diseases

Taku Fukuzawa, Zenjiro Sampei, Kenta Haraya et al. · Scientific Reports · 2017 · 107 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Anti-factor IXa/X bispecific antibody ACE910 prevents joint bleeds in a long-term primate model of acquired hemophilia A

Atsushi Muto, Kazutaka Yoshihashi, Minako Takeda et al. · Blood · 2014 · 93 citations · Full text

Medicine, Hematology, Immunology +10

Antibody engineering to generate SKY59, a long-acting anti-C5 recycling antibody

Zenjiro Sampei, Kenta Haraya, Tatsuhiko Tachibana et al. · PLoS ONE · 2018 · 60 citations · Full text

Pharmacy, Immunology, Pharmacology +17

1–5 of 10